Follow
Rimal Mousa
Rimal Mousa
Associate professor
Verified email at ju.edu.jo
Title
Cited by
Cited by
Year
Role of pharmacists in COVID-19 disease: a Jordanian perspective
MA Jalil, MM Alsous, KA Hammour, MM Saleh, R Mousa, EA Hammad
Disaster Medicine and Public Health Preparedness 14 (6), 782-788, 2020
342020
Perceived public stress among Jordanians during the COVID-19 outbreak
MHA Jalil, MM Alsous, EA Hammad, R Mousa, MM Saleh, KA Hammour
Disaster medicine and public health preparedness 16 (1), 240-244, 2022
112022
Direct medical costs of breast cancer in Jordan: cost drivers and predictors
R Mousa, E Hammad, J Melhem, M Al-Jaghbir
Expert Review of Pharmacoeconomics & Outcomes Research 21 (4), 647-654, 2021
8*2021
Awareness, knowledge, and attitudes of health professions students toward health economics and pharmacoeconomics education in Jordan
EA Hammad, R Mousa, AA Hammad, M Al-Qudah
Currents in Pharmacy Teaching and Learning 12 (9), 1072-1080, 2020
72020
Hospital unit costs in Jordan: insights from a country facing competing health demands and striving for universal health coverage
EA Hammad, I Alabbadi, F Taissir, M Hajjwi, NM Obeidat, Q Alefan, ...
Health Economics Review 12 (1), 11, 2022
52022
Cost-effectiveness of pharmacist-led care versus usual care in type 2 diabetic Jordanians: a Markov modeling of cardiovascular diseases prevention
E Mousa, Rimal, Hammad
Expert Review of Pharmacoeconomics & Outcomes Research, https://doi.org/10 …, 2020
4*2020
Epidemiology of women diagnosed with breast cancer in Jordan: A 5-year survival analysis and patients’ characteristics from 2 public hospitals
RH Mousa, JM Melhem, EA Hammad
Saudi Medical Journal 42 (7), 776, 2021
32021
Understanding health costs in the Jordanian public health sector: analysis of the cost-to-charge ratio
EA Hammad, R Mousa, E Massad, I Alabbadi
Journal of Pharmaceutical Health Services Research 13 (2), 151-157, 2022
12022
An evidence-based model design to inform the cost-effectiveness evaluation of primary endocrine therapy and surgery for older women with primary breast cancer
R Mousa, LC Chen, KL Cheung
Value in Health 17 (7), A638, 2014
12014
Perceptions about a pharmacy-delivered weight management service in community pharmacy settings in Jordan
G Al-Taani, R Arabyat, R Mousa
Journal of Applied Pharmaceutical Science, 2024
2024
COST-EFFECTIVENESS OF PHARMACIST-LED CARE VERSUS USUAL CARE IN TYPE 2 DIABETIC JORDANIANS: A MARKOV MODELING OF CARDIOVASCULAR DISEASES PREVENTION
R Mousa
VALUE IN HEALTH 25 (1), S60-S60, 2022
2022
POSC228 Hospital Unit Costs in Jordan: An Analysis Where Competing Demands Meets with a Thrive for Better Financing of Universal Health
E Hammad, I Alabbadi, T Fardos, M Hijawi, N Obeidat, Q Alefan, R Mousa
Value in Health 25 (1), S163, 2022
2022
Cost-effectiveness of primary endocrine therapy comparing against surgery as the initial treatment strategy in older women with primary breast cancer
R Mousa
University of Nottingham, 2017
2017
Cost Effectiveness of Primary Endocrine Therapy Against Surgery for Older Women with Primary Breast Cancer
R Mousa, L Chen, K Cheung
Value in Health 19 (3), A152, 2016
2016
An evidence-based model designed to inform the cost-effectiveness evaluation of surgery versus primary endocrine therapy for older women with primary breast cancer
R Mousa, LC Chen, KL Cheung
FUTURE ONCOLOGY 11 (4), 21-21, 2015
2015
An Evidence-Based Economic Model Design to Evaluate the Cost-Effectiveness of Primary Endocrine Therapy Compared with Surgery for Older Women with Primary Breast Cancer
R Mousa, LC Chen, KL Cheung
Cost-effectiveness of primary endocrine therapy against surgery for older women with primary breast cancer: An economic evaluation alongside observational study
R Mousa, LC Chen, KL Cheung
The system can't perform the operation now. Try again later.
Articles 1–17